Mutant screening for oncogenes of Ewing's sarcoma using yeast.
Appl Microbiol Biotechnol
; 99(16): 6737-44, 2015 Aug.
Article
in En
| MEDLINE
| ID: mdl-25936378
ABSTRACT
Many fusion genes, which are the result of chromosomal translocation and work as an oncogene, have been recently identified, but their mode of actions is still unclear. Here, we performed a yeast mutant screening for oncogenes of Ewing's sarcoma to easily identify essential regions responsible for fusion protein functions using a yeast genetic system. Three kinds of oncogenes including EWS/FLI1, EWS/ERG, and EWS/E1AF exhibited growth inhibition in yeast. In this screening, we identified 13 single amino acid substitution mutants which could suppress growth inhibition by oncogenes. All of the point mutation positions of the EWS/ETS family proteins were located within the ETS domain, which is responsible for the interaction with a specific DNA motif. Eight-mutated residues within the ETS domain matched to 13 completely conserved amino acid residues in the human ETS domains. Moreover, mutants also showed reduced transcriptional activities on the DKK2 promoter, which is upregulated by the EWS/ETS family, compared to that of the wild type. These results suggest that the ETS domain in the EWS/ETS family proteins may be a primary target for growth inhibition of Ewing's sarcoma and that this yeast screening system can be applied for the functional screening of the oncogenes.
Full text:
1
Database:
MEDLINE
Main subject:
Sarcoma, Ewing
/
Trans-Activators
/
Genetic Testing
/
Proto-Oncogene Proteins
/
Adenovirus E1A Proteins
/
Proto-Oncogene Protein c-fli-1
/
Mutant Proteins
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limits:
Humans
Language:
En
Year:
2015
Type:
Article